SCHEMBL855934

SCHEMBL855934

CC(O)c1ncco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19267208 1.00
SCHEMBL19267216 1.00
SCHEMBL16406106 0.82 CYP3A4 (0.34)
SCHEMBL8502640 0.80
SCHEMBL682658 0.80
SCHEMBL9368081 0.76
SCHEMBL22849475 0.76
SCHEMBL2534441 0.76
SCHEMBL22541400 0.76 FFAR2 (0.31)
SCHEMBL22021956 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6995271-B2 Production method of isoxazolidinedione compound JAPAN TOBACCO, INC. (JP) 2006-02-07 US claimed
US-20050159466-A1 PRODUCTION METHOD OF ISOXAZOLIDINEDIONE COMPOUND JAPAN TOBACCO, INC. 2005-07-21 US claimed
EP-0992503-B1 PROCESS FOR PRODUCING ISOOXAZOLIDINEDIONE COMPOUND JAPAN TOBACCO INC (JP) 2004-02-04 EP claimed
EP-1375499-A1 Process for the production of 2-(5-methyl-4-oxazolyl)ethanol derivatives JAPAN TOBACCO INC. (JP) 2004-01-02 EP claimed
US-20020188133-A1 Production method of isoxazolidinedione compound JAPAN TOBACCO, INC. 2002-12-12 US claimed
US-6444827-B2 FROM BETA-METHYL L-ASPARTATE VIA CHEMICAL INTERMEDIATE; EFFICIENCY; ANTIDIABETIC AGENTS JAPAN TOBACCO INC. (JP) 2002-09-03 US claimed
US-20010039352-A1 Production method of isoxazolidinedione compound ANDO KOJI (JP) 2001-11-08 US claimed
US-6248897-B1 FROM BETA-METHYL L-ASPARTATE JAPAN TOBACCO INC. (JP) 2001-06-19 US claimed
EP-0992503-A1 PROCESS FOR PRODUCING ISOOXAZOLIDINEDIONE COMPOUND JAPAN TOBACCO INC. (JP) 2000-04-12 EP claimed
EP-4741018-A2 SULPHONAMIDE COMPOUNDS Anaxis Pharma Pty Ltd (AU) 2026-05-13 EP disclosed
US-12583836-B2 Sulphonamide compounds Anaxis Pharma Pty Ltd (AU) 2026-03-24 US disclosed
EP-4168401-B1 SULPHONAMIDE COMPOUNDS Anaxis Pharma Pty Ltd (AU) 2026-01-07 EP disclosed
US-20250074891-A1 BIFUNCTIONAL SULPHONAMIDE COMPOUNDS Anaxis Pharma Pty Ltd (AU) 2025-03-06 US disclosed
US-20230227429-A1 SULPHONAMIDE COMPOUNDS Anaxis Pharma Pty Ltd (AU) 2023-07-20 US disclosed
US-20020188133-A1 Production method of isoxazolidinedione compound JAPAN TOBACCO, INC. 2002-12-12 US disclosed
US-6444827-B2 FROM BETA-METHYL L-ASPARTATE VIA CHEMICAL INTERMEDIATE; EFFICIENCY; ANTIDIABETIC AGENTS JAPAN TOBACCO INC. (JP) 2002-09-03 US disclosed
US-20010039352-A1 Production method of isoxazolidinedione compound ANDO KOJI (JP) 2001-11-08 US disclosed
US-6248897-B1 FROM BETA-METHYL L-ASPARTATE JAPAN TOBACCO INC. (JP) 2001-06-19 US disclosed
EP-0992503-A1 PROCESS FOR PRODUCING ISOOXAZOLIDINEDIONE COMPOUND JAPAN TOBACCO INC. (JP) 2000-04-12 EP disclosed
WO-1998050041-A1 NOVEL PRODRUGS COMPRISING FLUORINATED AMPHIPHILES IMARX PHARMACEUTICAL CORP. (US) 1998-11-12 WO disclosed